Karyopharm Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Karyopharm Therapeutics

06/08/2024 14:31

* Karyopharm Therapeutics Inc  KPTI.OQ  reported quarterly
adjusted earnings of 15 cents​​ per share for the quarter ended
in June, higher than the same quarter last year, when the
company reported EPS of -29 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 30 cents per
share. Wall Street expected results to range from -33 cents
to -20 cents per share.
    * Revenue rose 13.9% to $42.79 million from a year ago;
analysts
expected $36.18 million. 
    * Karyopharm Therapeutics Inc's reported EPS for the quarter
was
15 cents​.
    * The company reported quarterly net income of $23.79
million.
    * Karyopharm Therapeutics Inc shares had risen by 0.4% this
quarter and gained 0.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Karyopharm
Therapeutics Inc is $5.00 
This summary was machine generated from LSEG data August 6 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.30          0.15           Beat
 Mar. 31 2024      -0.33          -0.32          Beat
 Dec. 31 2023      -0.31          -0.36          Missed
 Sep. 30 2023      -0.28          -0.30          Missed